In contrast, thrombin potential remained relatively equal to non‐inhibitor patients and did not show a decreasing trend over time.
← all excerpts
Pharmacodynamic monitoring of factor VIII replacement therapy in hemophilia A: Combining thrombin and plasmin generation.
1
—
—